某医院患者鲍曼不动杆菌感染临床分布及耐药性变迁

发布时间：2018-04-25 11:37

本文选题：鲍曼不动杆菌 + 医院感染　；参考：《中国消毒学杂志》2015年02期

【摘要】：目的了解住院患者鲍曼不动杆菌感染的临床分布及耐药性变迁,为合理应用抗菌药物提供依据。方法通过对某医院临床感染患者送检病原学标本的检测,了解鲍曼不动杆菌感染的临床分布和耐药性状况。结果该医院每年从临床分离的鲍曼不动杆菌株数,由2006年的12株增加到2013年的72株;每年检出的鲍曼不动杆菌感染病人有50%以上来自重症监护病房。临床分离鲍曼不动杆菌对头孢类抗菌药物耐药率从2006年的50%以下,增加到2013年的94%以上;对碳青霉烯类抗菌药物耐药率从2006年0,增加到2013年的60%以上。结论该医院住院病人鲍曼不动杆菌感染及耐药率均呈现逐年增加趋势,感染患者主要分布于重症监护病房,应加强监测,采取有效干预措施。
[Abstract]:Objective to investigate the clinical distribution and drug resistance of Acinetobacter baumannii infection in hospitalized patients and to provide evidence for rational use of antimicrobial agents. Methods the clinical distribution and drug resistance of Acinetobacter baumannii infection were investigated by examining the pathogenic specimens of a hospital. Results the number of Acinetobacter baumannii isolated from clinic increased from 12 strains in 2006 to 72 strains in 2013, and more than 50% of the patients with Acinetobacter baumannii infection were from intensive care unit every year. The resistance rate of Acinetobacter baumannii to antibiotics increased from less than 50% in 2006 to more than 94% in 2013, and the resistance rate to carbapenes increased from 0% in 2006 to more than 60% in 2013. Conclusion the infection rate and drug resistance rate of Acinetobacter baumannii in the inpatients of this hospital are increasing year by year. The infected patients are mainly distributed in the intensive care unit. The surveillance should be strengthened and effective intervention measures should be taken.
【作者单位】：景德镇市第二人民医院;
【分类号】：R515

【参考文献】